234 related articles for article (PubMed ID: 31315928)
21. The Disordered Region of the HCV Protein NS5A: Conformational Dynamics, SH3 Binding, and Phosphorylation.
Sólyom Z; Ma P; Schwarten M; Bosco M; Polidori A; Durand G; Willbold D; Brutscher B
Biophys J; 2015 Oct; 109(7):1483-96. PubMed ID: 26445449
[TBL] [Abstract][Full Text] [Related]
22. Seed sequence-matched controls reveal limitations of small interfering RNA knockdown in functional and structural studies of hepatitis C virus NS5A-MOBKL1B interaction.
Chung HY; Gu M; Buehler E; MacDonald MR; Rice CM
J Virol; 2014 Oct; 88(19):11022-33. PubMed ID: 25031347
[TBL] [Abstract][Full Text] [Related]
23. The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.
Solbak SM; Reksten TR; Wray V; Bruns K; Horvli O; Raae AJ; Henklein P; Henklein P; Röder R; Mitzner D; Schubert U; Fossen T
BMC Struct Biol; 2010 Oct; 10():31. PubMed ID: 20920334
[TBL] [Abstract][Full Text] [Related]
24. HCV NS5A and IRF9 compete for CypA binding.
Bobardt M; Hopkins S; Baugh J; Chatterji U; Hernandez F; Hiscott J; Sluder A; Lin K; Gallay PA
J Hepatol; 2013 Jan; 58(1):16-23. PubMed ID: 22902549
[TBL] [Abstract][Full Text] [Related]
25. Interaction study between HCV NS5A-D2 and NS5B using
Dujardin M; Cantrelle FX; Lippens G; Hanoulle X
J Biomol NMR; 2018 Jan; 70(1):67-76. PubMed ID: 29218486
[TBL] [Abstract][Full Text] [Related]
26. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.
Kaul A; Stauffer S; Berger C; Pertel T; Schmitt J; Kallis S; Zayas M; Lohmann V; Luban J; Bartenschlager R
PLoS Pathog; 2009 Aug; 5(8):e1000546. PubMed ID: 19680534
[TBL] [Abstract][Full Text] [Related]
27. Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.
Weng L; Tian X; Gao Y; Watashi K; Shimotohno K; Wakita T; Kohara M; Toyoda T
Biochim Biophys Acta; 2012 Dec; 1820(12):1886-92. PubMed ID: 22954804
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation.
Madan V; Paul D; Lohmann V; Bartenschlager R
Gastroenterology; 2014 May; 146(5):1361-72.e1-9. PubMed ID: 24486951
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
Nevers Q; Ruiz I; Ahnou N; Donati F; Brillet R; Softic L; Chazal M; Jouvenet N; Fourati S; Baudesson C; Bruscella P; Gelin M; Guichou JF; Pawlotsky JM; Ahmed-Belkacem A
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760125
[TBL] [Abstract][Full Text] [Related]
30. Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded.
Liang Y; Ye H; Kang CB; Yoon HS
Biochemistry; 2007 Oct; 46(41):11550-8. PubMed ID: 17880107
[TBL] [Abstract][Full Text] [Related]
31. Molecular and structural characterization of the domain 2 of hepatitis C virus non-structural protein 5A.
Liang Y; Kang CB; Yoon HS
Mol Cells; 2006 Aug; 22(1):13-20. PubMed ID: 16951545
[TBL] [Abstract][Full Text] [Related]
32. The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.
Chatterji U; Bobardt M; Selvarajah S; Yang F; Tang H; Sakamoto N; Vuagniaux G; Parkinson T; Gallay P
J Biol Chem; 2009 Jun; 284(25):16998-17005. PubMed ID: 19380579
[TBL] [Abstract][Full Text] [Related]
33. PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly.
Nguyen LP; Tran SC; Suetsugu S; Lim YS; Hwang SB
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801866
[TBL] [Abstract][Full Text] [Related]
34. Vinexin β Interacts with Hepatitis C Virus NS5A, Modulating Its Hyperphosphorylation To Regulate Viral Propagation.
Xiong W; Yang J; Wang M; Wang H; Rao Z; Zhong C; Xin X; Mo L; Yu S; Shen C; Zheng C
J Virol; 2015 Jul; 89(14):7385-400. PubMed ID: 25972535
[TBL] [Abstract][Full Text] [Related]
35. Cyclophilin inhibitors for the treatment of HCV infection.
Fischer G; Gallay P; Hopkins S
Curr Opin Investig Drugs; 2010 Aug; 11(8):911-8. PubMed ID: 20721833
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylated tyrosine 93 of hepatitis C virus nonstructural protein 5A is essential for interaction with host c-Src and efficient viral replication.
Klinker S; Stindt S; Gremer L; Bode JG; Gertzen CGW; Gohlke H; Weiergräber OH; Hoffmann S; Willbold D
J Biol Chem; 2019 May; 294(18):7388-7402. PubMed ID: 30862675
[TBL] [Abstract][Full Text] [Related]
37. Human MxB Inhibits the Replication of Hepatitis C Virus.
Yi DR; An N; Liu ZL; Xu FW; Raniga K; Li QJ; Zhou R; Wang J; Zhang YX; Zhou JM; Zhang LL; An J; Qin CF; Guo F; Li XY; Liang C; Cen S
J Virol; 2019 Jan; 93(1):. PubMed ID: 30333168
[TBL] [Abstract][Full Text] [Related]
38. DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.
Coelmont L; Hanoulle X; Chatterji U; Berger C; Snoeck J; Bobardt M; Lim P; Vliegen I; Paeshuyse J; Vuagniaux G; Vandamme AM; Bartenschlager R; Gallay P; Lippens G; Neyts J
PLoS One; 2010 Oct; 5(10):e13687. PubMed ID: 21060866
[TBL] [Abstract][Full Text] [Related]
39. Resensitizing daclatasvir-resistant hepatitis C variants by allosteric modulation of NS5A.
Sun JH; O'Boyle DR; Fridell RA; Langley DR; Wang C; Roberts SB; Nower P; Johnson BM; Moulin F; Nophsker MJ; Wang YK; Liu M; Rigat K; Tu Y; Hewawasam P; Kadow J; Meanwell NA; Cockett M; Lemm JA; Kramer M; Belema M; Gao M
Nature; 2015 Nov; 527(7577):245-8. PubMed ID: 26536115
[TBL] [Abstract][Full Text] [Related]
40. Transient structure and SH3 interaction sites in an intrinsically disordered fragment of the hepatitis C virus protein NS5A.
Feuerstein S; Solyom Z; Aladag A; Favier A; Schwarten M; Hoffmann S; Willbold D; Brutscher B
J Mol Biol; 2012 Jul; 420(4-5):310-23. PubMed ID: 22543239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
